Norflox (Norfloxacin)

Norfloxacin, the active ingredient in Norflox, is a fluoroquinolone antibiotic presented as an oral tablet for oral use. It is indicated for the treatment of uncomplicated urinary tract infections, acute prostatitis, gastrointestinal infections such as traveler's diarrhea, and respiratory tract infections in adult patients.

GNH USA supplies Norflox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European Union quality standards and provides regulatory‑approved batches to qualified healthcare institutions. Logistics are managed to ensure timely delivery across multiple continents.

Norflox is a fluoroquinolone antibiotic used to treat bacterial infections of several organ systems. - Uncomplicated urinary tract infections: eliminates common uropathogens such as Escherichia coli, reducing dysuria, frequency, and urgency. - Acute prostatitis: penetrates prostatic tissue to achieve bactericidal concentrations, aiding resolution of inflammation and pain. - Gastrointestinal infections (e.g., traveler's diarrhea): targets enteric pathogens like Campylobacter and Shigella, decreasing stool frequency and abdominal cramps. - Respiratory tract infections: covers susceptible strains of Streptococcus pneumoniae and Haemophilus influenzae, improving cough and fever. - Skin and soft‑tissue infections (when culture‑guided): provides effective bacterial clearance.

Norfloxacin may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring shortly after dosing. - Diarrhea: loose stools that may be self‑limiting. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness or imbalance. - Abdominal pain: cramping or discomfort in the stomach region. - Photosensitivity: increased skin sensitivity to sunlight.

Serious or Rare Side Effects: - Tendon rupture or tendinitis: especially Achilles tendon, may occur during or after therapy. - QT interval prolongation: can lead to cardiac arrhythmias in susceptible patients. - Severe allergic reactions: including Stevens‑Johnson syndrome or toxic epidermal necrolysis.

When prescribing Norflox, clinicians should consider several safety measures to minimise risks. - Renal function: adjust use in patients with impaired kidney function. - Age: use cautiously in elderly due to higher risk of tendon injury. - Concomitant QT‑prolonging drugs: avoid combined use to reduce cardiac risk. - History of seizures: monitor closely as fluoroquinolones may lower seizure threshold. - Allergic history: discontinue if signs of hypersensitivity appear. - Store below 25°C: keep in the original pack, protect from moisture.

Norflox can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Antacids containing aluminium or magnesium: chelate the drug and markedly reduce absorption. - Warfarin: may enhance anticoagulant effect and increase bleeding risk. - Cyclosporine: increased plasma levels of both agents, raising toxicity potential.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may increase risk of CNS stimulation and seizures. - Corticosteroids: combined use may raise the chance of tendon rupture. - Diabetic agents (e.g., insulin, sulfonylureas): fluoroquinolones can affect glucose control.